tirzepatide making me throw up Managing Post-Injection Nausea and Discomfort

Do not take two doses at once

This article provides a summary of the weight reduction effectiveness, glycemic control, and safety of semaglutide (up to a 2.4-mg dose) and tirzepatide (up to a 15-mg dose), with a focus on the Semaglutide Treatment Effect in People with Obesity (STEP) 2, SURPASS-1, and SURPASS-2 trials, which involved patients with type 2 diabetes mellitus

This met the prespecified criterion for noninferiority but did not meet the threshold for statistical superiority

Primary endpoint: weight loss

Hitting three pathways at once is the logic behind why researchers expected and observed larger results